Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: An observational study

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 73-81

  Sabbatini, Massimo ^a   Garofalo, Gianluca ^a   Borrelli, Silvio ^b   Vitale, Sossio ^a   Torino, Massimiliano ^a   Capone, Domenico ^a   Russo, Luigi ^a   Pisani, Antonio ^a   Carrano, Rosa ^a   Gallo, Riccardo ^a   Federico, Stefano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adherence; Calcineurin inhibitors; Once daily tacrolimus; Renal transplant

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; TACROLIMUS;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIDNEY GRAFT REJECTION; LIFE SATISFACTION INDEX; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; TRANSPLANT CARE INDEX;

EID: 84892155845     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S54922     Document Type: Article

References (30)

1. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed September 12, 2012.
2. Prendergast MB, Gaston RS. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5:1305-1311.
3. Dew MA, Dimartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873.
4. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. Adv Ren Replace Ther. 1997;4:46-54.
5. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functional renal transplant: a multicenter study. Transplantation. 1998;66:1718-1726.
6. Raiz LR, Kilty K, Henry ML, Ferguson RM. Medication compliance following renal transplantation. Transplantation. 1999;68:51-55.
7. Vasquez EM, Tanzi M, Benedetti E, Pollak R. Medication noncompliance after kidney transplantation. Am J Health Syst Pharm. 2003;60:666-669.
8. Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R. Nonadherence consensus conference summary report. Am J Transplant. 2009;9: 35-41.
9. Didlake RH, Dreyfus K, Kerman RH, van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988;20 Suppl 3:63-69.
10. de Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59: 340-347.
11. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77:769-776.
12. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388-399.
13. Weng FL, Israni AK, Joffe MM, Hoy T, Gaughan CA. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16: 1839-1848.
14. O'Grady JG, Asderakis A, Bradley R, et al. Multidisciplinary insights into optimizing adherence after solid organ transplantation. Transplantation. 2010;89:627-632.
15. Kuypers DR, Peeters PC, Sennesael JJ, et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation. 2013;95: 333-339.
16. Matas AJ, Halbert RJ, Barr ML, et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant. 2002;16:113-121.
17. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13-20.
18. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75:1223-1229.
19. Sabbatini M, Crispo A, Pisani A, et al. Sleep quality in renal transplant patients: a never investigated problem. Nephrol Dial Transplant. 2005;20:194-198.
20. Wallemacq P, Goffinet JS, O'Morchoe S, et al. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Ther Drug Monit. 2009;31:198-204.
21. Chisholm MA, Mulloy LL, DiPiro JT. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy. Clin Transplant. 2005;19:77-83.
22. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000;70:1240-1244.
23. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation. 1995;60:914-920.
24. Schäfer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616-626.
25. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993;55:51-56.
26. Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666-675.
27. Doesch AO, Mueller S, Konstandin M, et al. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a preexperimental study. Transplant Proc. 2010;42:4238-4242.
28. Urstad KH, Øyen O, Andersen MH, Moum T, Wahl AK. The effect of an educational intervention for renal recipients: a randomized controlled trial. Clin Transplant. 2012;26:E246-E253.
29. Hougardy JM, Broeders N, Kianda M, et al. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. Transplantation. 2011;91:566-569.
30. Guirado L, Cantarell C, Franco A, et al. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. Am J Transplant. 2011;11: 1965-1971.